Karthik Kuppusamy
At a glance: Karthik Kuppusamy is Svp, Clinical Solutions at Quest Diagnostics (DGX). Their latest SEC Form 4, filed Jun 8, 2026, reported a sale of $1.6M. On file: 0 purchase lines ($0) and 2 sale lines ($2.2M).
Disclosed holdings: about $3.5M of DGX stock: 13,510 shares reported on their latest Form 4 (filed Jun 8, 2026), valued at the Nov 19, 2026 close of $259.06. This counts only DGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Svp, Clinical Solutions at Quest Diagnostics Inc (DGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Karthik Kuppusamy's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 8SEC | DGXQuest Diagnostics Inc | Sell Plan | 8,14713,510 held (−38%) | $200.00 | $1.6M | +29.5% |
| Mar 6SEC | DGXQuest Diagnostics Inc | Sell | 2,62813,441 held (−16%) | $204.86 | $538K | +26.5% |
- Sell
Svp, Clinical Solutions Karthik Kuppusamy sold $1.6M of DGX at $200.00 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.
Follow Karthik Kuppusamy
Get one email when Karthik Kuppusamy files a new purchase or sale. Free.
At most one email a day about Karthik Kuppusamy, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.